Postoperative radioactive iodine administration for differentiated thyroid cancer patients.

Purpose of reviewRadioactive iodine (RAI) is administered postoperatively to the majority of thyroid cancer patients. No available study has demonstrated any benefit in low-risk patients.Recent findingsRAI should be used selectively in low and intermediate-risk patients, based on the surgical and pa